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INTRODUCTION
Dr. Webster: First, let me say how honored I am to be here to
honor Ed McGuire. I am proud to have been associated
with him for almost 30 years and I know the other panel
members will agree, Ed ‘‘wrote the book’’ on neurourology,
urodynamics, and female urology. This event is not Ed’s
retirement, but when he does retire he is going to leave a
tremendous void in our field.
Dr. Blaivas: First, I’d like to express my gratitude for being
invited as part of this distinguished panel and my gratitude to
my good friend Ed McGuire here. Whether the rest of you
realize it or not, so far, all of the answers to the questions that
have been posed and the answers to the subsequent questions
that are being posed, those answers are based on physiological
principles that Ed taught us. For those of you (it looks like most
of you) in the audience too young to know what it was like
practicing the specialty before Ed McGuire was around, these
concepts didn’t exist. Most of us build on concepts from an
earlier time. Most of our great original ideas are really the
original ideas of our forefathers. The same really can’t be said
of Ed. The kinds of problems that you are describing and the
words that we’re using today, such as compliance and leak
point pressure and concepts like the effects of the compliance
on the upper tract are all things that didn’t exist in our
knowledge base, before Ed, and for that I really personally owe
you a great deal of gratitude as does the rest of the scientific
community.
Dr. Stohrer: Let me first say I’m very much honored to be
here today and thank you very much for inviting me. The
previous speakers have already mentioned aspects about Ed.
I would add that Ed McGuire is one of the urologists who
have had a great influence on German Neurourology, and we
are all very happy to known him and to have had his help
whenever we needed him. We have invited him several times
to come to Germany to discuss most difficult cases, and we
always benefited from his knowledge and his vast experience.
We appreciate his opinion as that of an honest, critical and
committed scientist. Also we have always enjoyed his special
sense of humor and his ability to get straight to the point. We
thank you very much, Ed!
CASE #1 PRESENTATION—MALE PATIENT WITH
OBLITERATED BLADDER NECK
The patient is a 65-year-old gentleman who had a radical
retropubic prostatectomy 6 years ago for localized prostate
cancer. Post-operatively he was continent. Two years after his
procedure he developed a PSA recurrence, and he underwent
salvage external beam radiation. One year after radiation
therapy he developed recurrent bladder neck contractures,
and he was treated with multiple urethrotomies and tran-
surethral resections. For the past 2 years, his bladder has been
managed with a suprapubic (SP) tube due to an impassible
bladder neck. His most recent PSA was undetectable. He has
had recurring urinary infections since the SP tube was placed
as well as one admission for pyelonephritis. He is otherwise
healthy besides being obese with a body mass index (BMI)
of 36.
Evaluation of this gentleman consisted of: Cystourethro-
scopy, which revealed a completely obliterated bladder neck;
and cystoscopy through his SP tract, which revealed normal
bladder mucosa and no other pathology. A cystogram revealed
a
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bladder capacity of 200 ml. He had poor bladder compliance
with a peak storage pressure of 80 cm water. There was no
evidence of detrusor overactivity or vesicoureteral reflux. No
contrast was seen entering the urethra.
To Dr. Webster: In this case would you try to re-open his
urethra, and if so, how would you accomplish this?
Dr. Webster: Yes, I would try and open the bladder neck
first. To re-establish continuity, I have a variety of techniques
and usually, but not always, I can accomplish my goal. I leave
a catheter in for variable time periods depending on how
much damage I leave at the time of my reestablishment of
continuity. Upon removal of the catheter there’s going to be a
period of self-calibration to let the system declare its stability,
and how long I will do that is determined by where on the
spectrum of complexity this man’s outlet resides. Some
ultimately prove to be recalcitrant even though I’ve estab-
lished continuity. By recalcitrant ones, I mean they’ll re-
obstruct, or they can’t do self-cath. In these instances, I will
consider stenting with Urolume1 as a means to keep it open. I
probably have a cadre of about 50–60 men who advanced to
the point of where they ultimately require stenting.
There are other complexities to this man’s case, obviously.
He’s got a seemingly bad bladder, but that may be a
combination of things that may be improved if one could
get his SP catheter out. It’s possible that his very limited
capacity is a fixed change due to the radiation. But I think a lot
of his bad bladder appearance may well be the result of a SP
tube being in for two years. The SP tube in of itself would not
deter me from re-establishing continuity. I’d try to get him on
self-catheterization, and then consider stenting. Regardless of
stenting or not stenting he may still require an artificial
sphincter as well. So I’m going to walk down a path with this
man, and each man is going to be a little different.
Dr. Cameron: Are there any factors that would make you
decide not to pursue this path of trying to open up his urethra:
The small bladder, urethral appearance, or anything else?
Dr. Webster: I remember one man who had an obliteration
that looked as though it was recanalizable using my standard
up and down endoscopic approach. Intraoperatively with
endoscope in place I did a rectal exam and realized that
actually the rectal wall was adherent to the retro-symphysis
and the urethra stopped below it and the bladder was above it.
So any attempt at recanalization would have traversed his
rectum.
So there are some circumstances, particularly, where there
was a separation of anastomosis at the time post-prostatec-
tomy where the defect is catastrophic. Establishing continuity,
in this case, means that all you’ve created is a channel through
scar. Nothing is going to keep that open. Stenting won’t help
that; the scar can grow through it. So there are certain
circumstances related to the length of defect and other intra-
operative findings that perhaps would deter you. The urethra
obviously isn’t going to be a candidate for an artificial
sphincter subsequently.
Also, not all patients want to go through what is obviously
multistage management. My honest counseling to them is
that there is a 50 percent re-operation rate even for the
successful candidate. However, these are not frequent re-
operations and they’re endoscopically achievable, and so
depending on the patient it might be a worthwhile price to pay.
Dr. Cameron: If the urethra is not salvageable, what would
you do? Would you divert this person, or keep him with a SP
tube?
Dr. Webster: I would present the options: Live with your SP
catheter or have a diversion. The diversion can be appliance
dependent or a non-appliance dependent catheterizable
one. For the appliance dependent, I would usually favor an
ileovesicostomy as opposed to a ureterostomy or ileal loop.
If the patient wanted a continent catheterizable system, my
own personal experience is that I prefer to do a continent
reservoir separate from the bladder. I know that seems like an
anathema because while you’ve got good uretero-vesical
anastomosis, then why not put a catheterizable stoma down
to that bladder augmenting at the same time if needed.
I’ve always found that to be so much more difficult to do, to
get the stoma in the correct location. I have so much more
confidence in an isolated continent catheterizable ileocecal
right colon pouch that I generally try and go that way. The
problem then is if I do a continent catheterizable separate
system, I’ve got a de-functioned obstructed bladder at
the bottom. I’ve got to think about the cystectomy and that’s
going to play into my decision making. If this is going to be a
difficult post-radiation cystectomy in a patient who is not a
good candidate for that big a procedure, I’m going to be
leaning back toward leaving that bladder in place and doing
something to the bladder, an ileovesicostomy versus some sort
of catheterizable augmented system to the bladder.
Dr. Cameron: When you’re planning to reconstruct the
bladder, what factors do you use to decide if the bladder is
suitable for this?
Dr. Webster: I don’t think I have ever done a simple
Mitrofanoff type using whatever appendage one wishes as a
catheterizable stoma to an intact bladder. I have always
augmented the bladder at the time. So how good or bad the
bladder is doesn’t make much difference to me because I’m
going to make the bladder bigger by augmenting it anyway,
and my preference if I’m going to do a continent catheterizable
augment to the bladder, is to use the right colon with the
ileocecal valve as the continent mechanism. It is a system that
lends itself much more easily to placing the stoma where you
want it to be.
Dr. Cameron: Continent catheterizable stomas can be a
challenge in obese adults like this gentleman. What surgical
tips can you give to the audience regarding performing
continent catheterizable stoma in an obese patient?
Dr. Webster: For an isolated continent diversion, obesity
makes little difference to the difficulty or success of the
catheterizable stoma because with a right colon pouch using a
staple-reduced ileal limb as your efferent system you just
leave it a little longer, it comes straight out through the
abdomen, and obesity doesn’t make any difference to the
technicalities of it.
If you’re leaving the bladder intact and you’re making a
continent catheterizable system attached to the bladder, then
I would agree, it’s a different kettle of fish altogether. It’s going
to lead me more toward making an isolated continent
reservoir system as opposed to a continent or vented system.
Dr. Cameron: And do you aim for the stoma to be at the
umbilicus?
Dr. Webster: Never. The umbilicus has always been a special
part for me. I can’t desecrate it with a hole that may leak.
Dr. Cameron: Do any other of the panel members have any
comments they would like to add?
Dr. Blaivas: I’m not so disinclined to use the umbilicus. I do
think that in some patients, and particularly in obese patients,
that it offers the straightest and shortest path to the pouch
and that makes catheterizing easier.
In my experience, there is about a 30 percent chance of the
patient developing stomal problems over time. I’m not talking
necessarily about the first few years; some patient’s have
come back, 5, 10, and 15 years later with either stomal stenosis
or a difficulty catheterizing. The difficulty catheterizing is very
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often right at the junction of the efferent limb with the pouch
or bladder. For that reason, I think it’s really important to have
the shortest possible distance from the skin to the pouch, and
that often is in the umbilicus, but not invariably. Having said
this I mostly don’t put it in the umbilicus. I put it wherever I
can get the shortest and straightest path; I think that’s what
makes the difference.
Dr. Webster: When I was making Kocks, I think I had easily
a 70 percent stoma revision rate or efferent limb revision rate.
In the last 18 years since I’ve been doing right colon pouches I
have to say my revision rate for stenosis or catheterization
difficulties is certainly less than 5 percent.
Dr. Cameron: Dr. Webster, how do you treat a leaking
continent catheterizable stoma?
Dr. Webster: I don’t try injecting them with things to
bulk the stoma. I’ll re-explore them, take it apart and put
it back together again the way it was supposed to be. Most
often what I’ll end up doing is sort of wrapping part of
the cecum around the efferent ileal segment. It’s almost
enveloped and the hydrostatic compression helps to com-
presses the limb.
I take it apart and I look at it and I put it back together in a
fashion that makes it look like it will work, and usually it will.
Dr. Cameron: Do any of the other panel members have any
suggestions to correct the leaking continent catheterizable
stoma?
Dr. McGuire: I sometimes will repair them with a sling.
I can put a rectus fascial sling around them, but you have to
make a slit and pull the sling through so that you can adjust
the tension, and that often works and it’s a pretty easy
operation to do. I would do that with an appendix, certainly.
CASE #2 PRESENTATION—SPINIA BIFIDA AND INCONTINENCE
This is a 28-year-old man with spina bifida whose bladder is
managed with self-catheterization and an oral anticholinergic
medication. He is incontinent only with transfers and with
physical activity. He has no prior history of bladder or bladder
neck surgery. He is employed, compliant with treatment, and
highly motivated to become dry. He is otherwise healthy and
has no urinary tract infections or stones.
On physical examination the patient is seated in a wheel-
chair. He has a normal GU exam. He has a favorable body
habitus with a BMI of 20. His 24-hr pad weight test is 400 g
and his urinalysis is normal.
On video-urodynamics, he has normal compliance up to
600 ml, and no evidence of detrusor overactivity or reflux.
With a cough there is intrinsic sphincter deficiency (ISD) with
a leak point pressure of 50 cm of water.
This is an image from his video-urodynamics. Note the
open bladder neck at rest. The bladder is filled to only 100 cc
with a cough test, although the patient can easily fill to
600 ml. The catheter is removed to better assess leakage and
the leak point pressure is 50 cm of water (Fig. 1).
Dr. Cameron: Dr. McGuire does his pad weight of 400 g in
24 hr affect your surgical plan?
Dr. McGuire: No, it doesn’t.
Dr. Cameron: Even if his pad weight were 800 g?
Dr. McGuire: It wouldn’t make any difference.
Dr. Cameron: How do you manage ISD in a male who does
intermittent catheterization?
Dr. McGuire: There are basically four ways. You can do a
fascial sling around the bladder neck. You could do a sling at
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Fig. 1. Bladder filled to 100 ml and catheter removed. Note the open bladder and urine leakage into urethra after
cough.
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the bulb. You could do an artificial sphincter implanted
around the prostatic urethra, or you could do a bone anchored
perineal sling. It would depend on their body habitus.
Myelodysplatic patients sometimes have a small pelvis, but
any one of those ways would work. The problem with a
bulbous urethral sphincter is that if they are doing an
intermittent catheterization it often erodes.
Dr. Cameron: Do any of the other panel members have
anything they would like to add to that?
Dr. Stöhrer: We are doing fascial slings in these cases,
and they are very effective. I am not so much in favor of
bone anchors. I think it’s much better to have your own
tissue in these cases because these are mostly young people
and if it’s not effective, you could later do an artificial
sphincter. This is what we are currently doing. We start
with a fascial sling and then the next step would be to do a
sphincter.
Dr. McGuire: Actually our data for bone anchored slings in
patients with myelodysplasia is excellent. I’m not sure why
that is. It’s better than for postprostatectomy incontinence,
and they’re stable for years. We have 6-year data. I’m sort of
torn between a standard fascial sling or a periprostatic sling
and a bone anchored sling because the bone anchored sling is
not very invasive and I can do it in about 30 min and our
results are excellent. I wouldn’t have thought that it’s possible
in this patient group since they don’t have normal bones, but
the results are good.
Dr. Cameron: Dr. McGuire, how do you feel about
synthetic materials implanted in a person who does self-
catheterization?
Dr. McGuire: Well, I don’t think you’re going to get away
with a bulbous urethral sling, but the bone anchored slings
are not an impediment to re-instrumentation of the urethra.
A bone anchored sling will let you get a rigid or a flexible
scope into the bladder, and it’s not a problem with
intermittent catheterization, but neither really is a prostatic
urethral artificial sphincter. They do erode, but it takes a
long time.
Dr. Webster: I have no experience with Invance1 slings
in this population because I always put a bladder neck
sphincter in this population. I must say bladder neck
sphincters, other than the difficulty of the dissection for
placement, have the same difficulty as doing a bladder
neck sling. I hate to do a bladder neck sling thinking I could
end up in that location placing a sphincter because I’ve
messed up that field and the dissection is going to be that
much more difficult the next time around to put a bladder
neck cuff in. So I’ve invariably gone with a sphincter cuff, and
they are the longest surviving of all sphincters. I’ve got
some 14–16 years still functioning, unlike the customary
5–10 years survival of the bulbar urethral cuffs and they do
work pretty well.
Dr. McGuire: I certainly agree, although I have seen bladder
neck sphincters erode in time, and I’ve salvaged those with a
fascial wrap sling. Not an easy operation, but I salvage them.
So you can do it.
Dr. Blaivas: Like George, I predominantly place the
sphincter around the prostatic urethra for these patients.
The other advantage to the sphincter is occasionally there are
people who can void and don’t need to catheterize themselves.
You mentioned a leak point pressure of 50 cm of water,
which is fairly high for this condition and that patient might
not be able to void, but some of the patients have so little
resistance you can put in an artificial sphincter and they can
void to an acceptable degree with reasonable pressures and
they don’t even need to catheterize.
Dr. Cameron: If your artificial sphincter fails, and you’ve
tried slings and they’ve failed, would you consider a bladder
neck closure and a continent catheterizable stoma in this
man?
Dr. McGuire: I wouldn’t do that. I think the difficulty in
getting him dry with a sphincter or a sling is surmountable.
There are issues in this person of fertility and so forth.
CASE #3 PRESENTATION—FEMALE URETHRAL EROSION
This is a 45-year-old woman who has progressive multiple
sclerosis (MS). She is functionally tetraplegic and is unable to
perform self-catheterization. She had a urethral catheter
placed 5 years ago to manage her urinary incontinence. She
developed leaking around the catheter and over the course of
the 5 years the catheter was gradually up-sized from 16 French
up to 24 French with continued leakage around the catheter.
Later the volume in the balloon was increased. Her urethra
became destroyed to the point where the catheter, even with
30 ml in the balloon, was repeatedly falling out.
Other than the progressive MS and her recurrent urinary
tract infections, her past medical history is unremarkable. She
has normal renal function with a creatinine of 0.6 mg/dl. On
physical exam, her urethra is essentially wide open and would
admit two fingers (Fig. 2).
Dr. Cameron: Dr. Blaivas, how would you manage an open
bladder neck and a destroyed urethra in a woman who is
incontinent and cannot self-catheterize?
Dr. Blaivas: Managing a destroyed urethra in this kind of
woman to me is not easy, but it’s fairly straightforward
because there is only one technique that I use. I don’t try to
reconstruct the urethra in someone like this because I think
it’s doomed to failure. So I would just close the bladder neck
and do an ileovesicostomy.
Dr. Cameron: So what if she was able to learn self-
catheterization?
Dr. Blaivas: Well, this wouldn’t be an MS patient with
tetraplegia because in this kind of a situation even if she could
catheterize now, I wouldn’t want that burden to fall on
somebody else in the future. So let’s just pretend for the
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Fig. 2. Female urethra destroyed by urethral catheter.
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moment we just want to fix the urethra that someone could
catheterize, and then that depends on a couple of factors.
If it’s a quadriplegic or a paraplegic woman who has
spasticity in her legs and can’t catheterize through the
urethra, that’s probably the single most important consid-
eration. No matter how we reconstruct it and no matter how
good her hands are if she can’t get her legs apart to get the
catheter in, it’s simply not going to work. So if we’re going to
fix the urethra, then it has to be in someone that not only has
good hand function, but can physically assume the position
that she can catheterize herself. If that’s the case, what I do is
I reconstruct the urethra using adjacent vaginal tissue flaps. So
we have to assume that there’s enough local tissue in the
vagina to do that. There are a variety of different ways to do it.
I would find tissue in the vagina to roll into a tube or perhaps
make two rectangular flaps and bring them together and
make them into a tube and then wrap that tube with a
Martius flap from one side or the other and then put a sling
around that. I would expect her to be continent and able to
catheterize herself but not necessarily be able to void.
As for closing the urethra, what I do in a situation like this is
to do it from above as part of an augmentation cystoplasty
either along with a catheterizable stoma or in this lady we’d
probably use an ileovesicostomy where the urine just drains
into a bag. I transect what’s left of the urethra at the bladder
neck and then I dissect underneath between the bladder neck
and the vagina and make a little flap of the posterior part of
the bladder wall and then I use that as part of the closure
for the augmentation part of creating the reservoir. So the
posterior part of the bladder would come up, and we would
just anastomose it to whatever piece of bowel we’re using for
the cystoplasty. In this fashion, there is no longer a tubular
anatomy to what was the urethra, so if the muscle contracts, it
will not cause urine leakage.
Dr. Cameron: Any comments from the panel?
Dr. Webster: In a patient like this, I like to close the bladder
neck as well. However, bladder neck closures fail frequently,
no matter how well you seem to do it. Water finds its way back
out to the urethra and I’ve had a significant number of failures
in my career in bladder neck closures from above to the point
now where, providing the patient doesn’t have tremendous
spasticity, I will do a urethrectomy in lithotomy position to
start with. Then I will perform the ileovesicostomy from the
top. I’m not averse to doing it abdominally, but I will definitely
think hard about a urethrectomy done through an elliptical
incision around the meatus.
Dr. Cameron: Dr. Blaivas, do you have experience with an
ileovesicostomy versus an ileal conduit?
Dr. Blaivas: Yes, I do. The ileovesicostomy really works very
well. I did my first one in the mid-1980s after speaking to Ed
about what should I do with this type of patient, and this
happened to be a man who was quadriplegic and couldn’t care
for himself at all. That was over 20 years ago and I still see him
once a year. Stomal stenosis is practically unheard of after
ileovesicostomy and there is no chance of ureteral obstruction.
On the other hand, the incidence of ureteral obstruction after
ileal conduits is at least in the single digit percents and that is
not insignificant.
Dr. Webster: I think it was you and Ed wrote a paper about
urodynamics in ileovesicostomy systems, wasn’t it?
The interesting thing is an ileovesicostomy doesn’t always
turn out to be the totally safe system with a very low leak
point that you imagine. Maybe there’s some physical principle
by which that occurs, but certainly the fact that you’ve done
an ileovesicostomy and converted a low compliance bad
system into what you think is a free leak system doesn’t mean
you can forget about the patients. Sometimes these things
don’t have a low leak point pressure. Ed could comment on
that.
Dr. McGuire: It is still our standard technique, but they
don’t always drain perfectly and the bladder neck closure can
fail and then you have a disappointed person who has had a
big operation. I’ve become more and more careful about
making the anastomosis as big as possible, to put a flap of
bladder into the anastomosis and make them as low as
possible. Don’t make the anastomosis on the dome, bring
them down farther.
But I agree with Jerry and George that the loop and
cystectomy is a lot of surgery in a patient who’s fragile.
Dr. Stöhrer: I have a question. Does anyone see any
indication to leave in a catheter for 5 years? Because we have
seen so many of those patients, always with the same
problem.
Dr. McGuire: Well, the problem is that the person who
makes the decision to put the catheter in is never the person
that has to look after the problem. It’s always somebody else.
Once you lose a patient like this for 5 years with a catheter, the
damage is done. Then they risk the skin, and if the skin breaks
down, they risk osteomyelitis and then they risk their life.
CASE #4 PRESENTATION: REFRACTORY DETRUSOR
SPHINCTER DYSSYNERGIA
This is a 24-year-old gentleman who suffered a C7
spinal cord injury 4 years ago. He has adequate upper
extremity function to be able to perform intermittent
self-catheterization. He catheterizes every 3 hr and is on
oxybutinin 15 mg daily. He is wet between catheterizations,
but is otherwise healthy.
As part of a workup his ultrasound showed no bladder
stones, but mild bilateral renal dilation. His urine culture was
negative and his creatinine was normal at 1.2 mg/dl.
On urodynamics, he has a small capacity low compliance
bladder with an intravesical pressure of 34 cm of water with
only 130 ml of filling. He also has left grade 1 vesicoureteral
reflux. During the voiding phase there is detrusor sphincter
dyssynergia (DSD) (Fig. 3).
Dr. Cameron: Dr. Stöhrer, what would your initial manage-
ment be of this problem?
Neurourology and Urodynamics DOI 10.1002/nau
Fig. 3. Fluorourodynamic image at 130 ml of filling with a detrusor
contraction and detrusor sphincter dyssinergia.
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Dr. Stöhrer: This is a common situation in a patient with a
C7 spinal cord injury. What we would do first is urodynamics.
In this case, we would try to decrease the bladder
pressure during storing phase by anticholinergics. If this
works, the patient has to do catheterization, and this is
something he could do indefinitely. But many of the patients
are not very satisfied with their clinical response to anti-
cholinergics. This may be due to side effects or lack of efficacy,
or both. In these instances, we consider botulinum toxin
injections. At the moment, we have about 500 patients we are
following up who have had botulinum toxin, and I think this
is a good second step. Then if it’s not working, we have some
other options, including perhaps an auto-augmentation.
Dr. Cameron: In an ideal world where cost and insurance
coverage weren’t an issue, what would your treatment be?
Dr. Stöhrer: My treatment would be to put the patient on
aseptic intermittent catheterization four to five times a day
and perhaps botulinum toxin. From my personal point of
view, I would recommend botulinum toxin.
Dr. Cameron: Do any of the panel members have anything
to add to that?
Dr. McGuire: No. I would do that. I learned from Manfred.
The first long-term series published was the combined Murnau,
Zurich experience with botulinum toxin in this patient
population. This patient is an ideal candidate for that therapy.
Dr. Blaivas: I certainly agree with the efficacy of botulinum
toxin and Dr. Stöhrer’s studies in particular have shown that.
An augmentation cystoplasty, though, is an awfully good
solution as well. If I were the patient, I think I might prefer
augmentation cystoplasty, and catheterization. I have person-
ally followed over 100 of my patients after enterocystoplasty
for 10 years or more, and aside from two men who developed
urethral strictures that had to be managed endoscopically, I
find it a very trouble-fee existence. They catheterize three to
four times in 24 hr, and the problem of cancer I think is
practically nonexistent in this patient population.
What do you think about that?
Dr. Webster: When I think of this particular practice, the
spinal cord injury practice, I see a case being presented to me
by residents or fellow as a great candidate for an augmenta-
tion cystoplasty. When you actually look at the cases
individually, you’ve got to be sure that this rather large
operation is the appropriate choice.
It can be challenging to get a spinal cord injury patient who
has a limited cystometric and functional capacity to accept the
fluid limitations that it’s going to take to have to only be able
to catheterize every 3–4 hr and to take medications that carry
side effects and to have the compliance to buy and take the
medication. However, if one does all those things, you actually
don’t need to do as many cystoplasty procedures that we
resort to appease a noncompliant patient. If I was the patient,
I wouldn’t like to catheterize that often and take all those
meds and I’d like to drink more fluids. So perhaps it’s okay to
say, ‘‘You could be better on your own, but since you can’t
comply with maximal conservative therapy, we’re going to
augment you, or inject you with botulinum toxin.’’ But I’d like
our residents to understand that line of thinking, that’s why
we’re doing this and not because we’ve failed.
Just one other thing, Manfred- in using botulinum
toxin for neurogenic overactivity, accepting its function in
hyperactivity with involuntary contractions, do you see
the same sorts of results with this sort of low compliance
system?
Dr. Stöhrer: Yes, because there is usually not an organized
fibrosis. Instead, there is detrusor overactivity which causes
the compliance abnormality, and this is something you can
help with the botulinum toxin. At the moment, we are
treating more than 70 percent of our patients from this
population conservatively. We don’t need many subsequent
procedures. Personally, I wouldn’t want a piece of my bowel as
a bladder because this is not a normal bladder. It is a good
surgical procedure, but I think from the patient’s point of
view, most say they would prefer to be on conservative
management as long as possible. This is my experience. They
do catheterize four to five times a day, have few fluid
problems, and drink normally (about one and a half liters
per day).
Dr. Cameron: Dr. Stöhrer, what are your feelings about the
long-term use of botulinum toxin in this patient population?
Dr. Stöhrer: We now have 11 years of experience—some of
the patients have had up to 12 injections. In my hospital
last week, I checked how many of our patients had developed
antibodies, and there were only six patients out of > 500.
So I think it is a very small number. The only side effect we
have seen is that some of the patients (<2%) had a systemic
reaction of 2 weeks maybe, 3, 4 weeks where they feel
lethargic (without any necessity for an intervention). This is
the only complication we have seen up to now.
Dr. Cameron: How many injections do you do and where do
you do the injections in the bladder?
Dr. Stöhrer: I am not sure that the specific technique has a
significant effect on the outcomes, but here is what we do. We
usually inject 300 units of Botox1 using 30 injections, which
equals one milliliter for ten units or 750–1000 units of
Dysport1. We inject it at random sites throughout the bladder,
but I believe that if you do it 15 times over the whole bladder,
there’s no difference in the outcomes.
CASE #5 PRESENTATION: MESH EROSION INTO THE URETHRA
This is a 75-year-old female who has incontinence after
undergoing a trans-obturator tape (TOT) procedure. Initially
she had stress incontinence using four light pads per day.
After evaluation at an outside facility she underwent TOT
placement. Unfortunately, the incontinence was much worse
after the procedure, so that the patient, required diapers.
She did not complain of any hesitancy or straining, nor did she
note any dysuria, urgency, or urge incontinence.
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On pelvic exam, the tape was non-palpable. There was
no fistula found. Incontinence was seen only via the
urethra with Valsalva. Significant atrophy of the vagina was
also noted and there was no post void residual. The urinalysis
was notable only for microhematuria. On cystoscopy, one
can clearly see the polyproprylene mesh which was eroding
through the lateral wall of the urethra right at the bladder neck
(Fig. 4).
She subsequently underwent urodynamics. Her leak point
pressure was 55 cm of water. There was no detrusor over-
activity noted.
Dr. Cameron: How would you surgically manage this case?
Dr. McGuire: Well, you have to take the tape out, and
I think if there’s any controversy, it’s what you have to do
subsequently. I normally would take the tape out, close the
injury site in the urethra, and let it settle down a bit before
I did a fascial sling. I’ve been tempted to do the sling at
the same time, but I have not yet done that.
Dr. Cameron: What would you counsel her about her risk of
incontinence after removal of the tape?
Dr. McGuire: 100 percent.
Dr. Cameron: So you would not prophylactically implant a
new sling?
Dr. McGuire: Normally I’m most worried about what the
urethra looks like. The tape is through the middle of it. Here it’s
right on the side of the bladder, and I think you’re better off
getting it out of there before you put a sling in. Even though
there’ll be scarring and difficulty at the time of the next
surgery, generally speaking I wouldn’t put a sling in now. I’m
not sure why I do that, but I do.
Dr. Cameron: There are reports of people simply excising
the tape endoscopically with a zero degree lens on a
cystoscope and scissors or actually using a nasal speculum
and trimming the tape and not opening up the urethra. How
do you feel about that method?
Dr. McGuire: I don’t know how you would do that at the
bladder neck and be sure you got it all out.
Dr. Webster: I think this one’s interesting: Looking at the
endoscopic image it is located at the side of the bladder neck
(Fig. 4). It looks more like it was a trochar passage problem
where they skived the edge of the bladder neck as they
traversed it with the trochar rather than the customary
problem that we see more often, which is the sling rising
through the floor of the urethra almost as a gate either across
the middle of the urethra or rising up from the floor of the
urethra. I think that’s either a tension problem or more likely
I think it’s a dissection problem.
Dr. McGuire: I think this is a dissection problem. It’s an
unusual place for a sling erosion. Usually they’re posterior.
Dr. Cameron: Dr. McGuire, why do you think her incon-
tinence is worse after the TOT?
Dr. McGuire: I think the tape does something to the urethral
continence mechanism it’s in it or it’s around it and it doesn’t
work as well. So when you take the tape out and you look,
they have gone from a simple types 1 or 2 incontinence to
type 3 with ISD. They get worse.
Dr. Cameron: In this case, the tape was excised widely from
the urethra and then the urethra was reconstructed. She was
advised of the high risk of incontinence, but she simply
wanted the tape removed due to overall poor health and did
not want any abdominal or SP incision. Her incontinence
actually improved somewhat, but she is still using heavy pads.
Do we have any other comments from the panel about
managing this differently?
Dr. Blaivas: Yes. I see a fair number of these. I do what I call
a radical slingectomy, and what that means is we get the tape
on either side of the urethra and just excise it as if it were a
cancer, and that means we take a good bit of healthy urethra
with it, and then at the same operation the urethra is
reconstructed, a Martius flap is placed over the repair and an
autologous rectus fascial sling is positioned over the Martius
flap.
We haven’t reported this data yet. We’re putting it together
now, and it’s not a large series. We haven’t had any fistulas,
and virtually all of the patients have been cured or much
improved with respect to continence. The most difficult to
manage problems in these patients has been pelvic pain and
overactive bladder.
Dr. Webster: I take the other end of the spectrum. I try to be
as non-radical as possible actually and do as little further
damage to the urethra as possible. So, like you, I do try and
identify the sling on each side of the urethra because going for
it in the middle you will actually cause further injury to the
urethra. If you can identify the sling laterally on each side you
can cut it on both sides and then peel it out. You’ll end up then
with a much cleaner posterior urethral defect, which I close
with interrupted 5–0 Vicryls and get as many layers over as
possible.
To inject a little of what I know will be controversial, I don’t
do a second sling at the same sitting, and I rarely put in a
Martius flap unless there is just nothing to cover the
defect with. I’d rather redeploy a flap of vaginal wall over
the urethra so that when I come back for a second sling I am
operating through more normal vaginal wall. Fortunately
with mid-urethral slings done the way they are today,
generally the injury is going to be quite localized and luckily
the proximal third of the urethra is probably going to be
okay.
So I most frequently still use a trochar delivered synthetic
sling as my second procedure. Because the patient was
snake bit with a synthetic sling one time, should one
blame the synthetic material or could it be operator dissection
error? Most times I think it is the latter and I therefore feel
comfortable using a synthetic the second time providing I’m
in a new location and tissues are healthy and I can get good
vaginal wall cover.
Dr. Blaivas: I should have qualified what I said. Most of
the patients that I’m talking about don’t just have the
sling erosion. They have the erosion and they have stress
incontinence and they complain of pain. There are lots of
components that we’re treating other than just the stress
incontinence. I often see patients that have already had one
attempt at removing the sling. When you go back there are
still strands of sling all over the place and they’re getting
recurring infections. If it was just a really simple straightfor-
ward case of only stress incontinence and no other problems,
I might be more willing to do a more minimalist approach. But
maybe not!
Dr. McGuire: It is an inexact science because where they’re
supposed to be, they may not be. You may find a mid-urethral
retropubic sling up by the bladder neck. You may find a TOT
where you don’t expect it. If there’s any doubt about where it
is, you can find it with a transvaginal or perineal ultrasound.
The tape lights up and it’s a huge advantage.
We have 12 people in our series of 80 takedowns that
supposedly had already had the sling removed and nine of
them still had a perfectly intact sling. So someone had gone in,
looked for it and couldn’t, find it or mistakenly concluded that
they must have cut it. You have to be absolutely sure to find it.
Dr. Webster: I think my series is the same. Twenty percent
of our sling takedowns are already supposedly taken down
and there’s still an intact sling there.
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CASE #6 PRESENTATION: URETEROSIGMOIDOSTOMIES
AND RENAL FAILURE
Our next case is a 40-year-old patient with a history of
bladder exstrophy. She underwent a cystectomy and bilateral
ureterosigmoidostomies as a child. As an adult she has had
a progressive increase in her creatinine up to 3.7 mg/dl,
although she has remained off of dialysis. She is being
evaluated for a living related renal transplantation and has
a potential donor. She was referred for urologic evaluation due
to pyelonephritis two to three times a year as well as recurrent
nephrolithiasis. These are thought to be the causes of her
chronic renal insufficiency.
As part of her urologic evaluation she underwent a CT scan,
which showed a normal right kidney except for mild
dilatation. However, the left kidney showed atrophy with a
staghorn calculus. Her renal scan showed greater than
90 percent of her function on the right.
Dr. Cameron: Dr. Stöhrer, what other evaluations would you
perform on this woman before deciding on a treatment plan?
Dr. Stöhrer: I think the most important thing is to make a
scan of the kidneys to see the function, and if you see there’s
only 10 percent on one side with a staghorn and on the other
side they are 90 percent, you should remove the kidney. I think
3.7 mg/dl for creatinine is not so bad. We could perhaps wait a
little bit and see how her creatinine progresses. The recurrent
infections may also improve after removing the left kidney.
Dr. Cameron: Since she is being worked up for a transplant,
how would you manage her other than the nephrectomy?
Would you do anything differently before her transplant?
Dr. Stöhrer: It’s probably good to have a side which is clear
for transplantation. If one does do anything, one should do it
so as not to interfere with where the transplant will be placed.
Dr. Cameron: This woman had a sigmoidoscopy done by
gastroenterology and had biopsies taken of her sigmoid colon.
There was no dysplasia, and she then underwent a laparo-
scopic left-sided nephrectomy. Later her ureterosigmoidos-
tomy was taken down. The ureters were taken off of the
sigmoid colon with a small cuff of bowel resected with them.
She had an ileocecal pouch created with the right native right
ureter implanted into the ileocecal pouch to drain her urine.
After waiting for a year with her creatinine remaining stable
she underwent the transplant (Fig. 5). She never required
dialysis.
Does the panel have anything to add to this case?
Dr. McGuire: No. I think that’s the right thing to do. Take out
the left kidney. Put the right kidney into the pouch to drain.
That’ll keep the pouch healthy while you wait for the
transplant, and then the transplant should go into the pouch.
That’s a good solution because you can’t put the transplant
into the ureterosigmoidostomy. The question in my mind is, if
you take the ureters out of the sigmoid, is the potential for
malignant transformation completely gone because you do
that or does it still stay there?
Dr. Webster: I think if you take the cuff with it, as they did,
then it’s gone.
Dr. McGuire: It should be gone.
Dr. Webster: I think this is a very elegant sequence of
surgical events. It is also likely what I would do given the
circumstances. However, one has to step back and accept it’s a
potentially morbid sequence of events. While the continent
reservoir is a good potential receptacle for a transplant kidney,
simpler might have been an appliance dependent ostomy
carrying less morbidity with it than constructing the colon
pouch, and I might have tried to persuade the patient that
way, but on the other hand, she’s 40 years old and she’s
accustomed to having no ostomy.
CASE #7 PRESENTATION: FEMALE BLADDER
OUTELT OBSTRUCTION
This is a woman who has an anatomic bladder outlet
obstruction. She is a 50-year-old woman who presented with a
2-week history of bloating, malaise, and some hypertension.
She feels that she has not been emptying her bladder
completely for the past several months. Otherwise, she is
very healthy. She had a cystoscopy done at age 20 after a urine
infection, and was told that it was normal.
She saw her primary care physician who palpated a 15 cm
right lower quadrant abdominal mass. Blood work showed
that her creatinine was 3.8 mg/dl where it had previously
been 0.8 mg/dl.
She was sent to the emergency department by her primary
care physician. In the emergency department, she was able to
void and did so twice for a total of 600 mm. An ultrasound was
performed and bilateral hydronephrosis was found, as well as
this mass. The mass measured 15 by 10 cm. It was located in
her pelvis and was found to have mural nodularity. A CT scan
confirmed bilateral hydronephrosis and the pelvic mass with
mural nodularity. The mass had septations and was complex
(Fig. 6A and B).
Urology was then consulted because of the hydronephrosis
and attempts were made to place a urethral catheter. The
catheter was not able to be passed because of significant pain,
but also because there seemed to be an obstruction in her
urethra.
She underwent bilateral percutaneous nephrostomy tubes,
and over the next 4 days while she was in the hospital her
creatinine decreased to 1.4 mg/dl and her blood pressure
returned to normal. Since she was now medically stable she
was taken to the operating room. On examination under
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side (white arrow) before ureter (with stent in place) tunneled under
sigmoid (black arrow) to the ileocecal pouch (grey arrows).
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anesthesia there was a membrane-like structure that required
dilation. It was dilated up to 16 French and then a catheter was
placed.
Her intra-op cystogram showed an interesting picture.
One can see a huge diverticulum off of this central area of
contrast, which is actually her bladder with the catheter in
place (Fig. 6C). With a repeat filling there was also a large
diverticulum seen on the other side.
After several weeks of catheter drainage she was brought
back as an outpatient for urodynamic studies.
Dr. Cameron: This is a voiding phase of her urodynamic
study. Here is her detrusor pressure. You can see her pressure
goes up to 195 cm of water and her flow is very slow (Fig. 7).
There is around 250 ml noted to be in her bladder after she
voided, and on fluoroscopy there are diverticula seen on both
sides.
Dr. Cameron: Dr. Blaivas, how would you manage her
bladder with obstruction now? She has a catheter in place and
she’s seeing you in the clinic.
Dr. Blaivas: To just back up, you said that at the time of
cystoscopy you saw this membrane kind of obstruction. I’ve
seen about 10 patients with something like this and in all of
them, at the time of cystoscopy, I couldn’t be sure of what I
was seeing. I was never really confident in any of my patients
that I understood what was causing the obstruction. Some of
them did have things that I thought was a membrane or a
flap but in retrospect I thought that it might be due to a false
passage.
So I’m not confident of the cystoscopic appearance in
someone like this but if you use the word membrane, the first
thing you think of is valves, and there have been very rare
reports in girls with female valves. I’m not sure any of them
ever exist, but that’s one possibility. I’ve never seen a female
valve, though.
In my experience, there is a limited differential diagnosis:
Primary bladder neck obstruction, urethral stricture or tumor
and acquired voiding dysfunction. The bladder neck obstruc-
tions have been overtly obvious at videourodynamics—there
is high voiding pressure and low flow and obstruction at the
bladder neck on the voiding film. Further, bladder neck
obstructions have not been difficult to catheterize. Treatment
is straightforward—you cut the bladder neck (transurethral
incision or resection) and they’re better, but that’s only a
handful of patients—it’s quite rare. Urethral strictures are rare
as well unless there has been prior urethral surgery. In my
experience, most have been at the mid urethra, but some are
at the distal urethra. The mid-urethral obstructions have been
all women between 30 and 45; the distal ones have been older
women with severe atrophic vaginitis.
The first part of management is to have a clear under-
standing of the anatomy, and for that I would take advantage
of the fact that I have a catheter in, and immediately upon
taking the catheter out I would get another urodynamic
study and see what anatomy I have now. If it is a bladder
neck obstruction I would recommend surgical treatment as
I previously described. If not, I would leave the catheter out
and let her void on her own at home, and I would bring her
back within a month. I would then check her flow rates
at monthly intervals, and I would expect within a month or
two the obstruction will recur. At the time of recurrence, we
will do another videourodynamic study and based on that, we
should be able to see exactly what the anatomy is. Depending
upon what the anatomy is, that’s how I would decide what to
do next. I’d have her voiding and coming back very frequently
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Fig. 6. Woman with bladder outlet obstruction. All white arrows indicate multiple bladder diverticula black
arrows indicate bladder. A&B CT scan of pelvis, C cystogram, D MRI of pelvis.
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for flow rates and if she’s reporting she’s having difficulty
voiding, come back sooner for retesting.
Dr. Cameron: She had a spine X-ray to rule out any
neurologic component to this and it was completely normal.
She was started on clean intermittent catheterization and had
a repeat urodynamics done 3 months later and she’s still
having these high pressure, low flow, voiding, and incomplete
emptying.
Dr. Cameron: Dr. Blaivas, how do you define bladder outlet
obstruction on a woman?
Dr. Blaivas: Almost everybody bases the diagnosis of
obstruction in women and in men on high pressure and low
flow, but there is some controversy about what the exact
cutoff numbers are, but certainly this case with a detrusor
pressure of 195 cm H2O of water and a flow of 3 to 4 ml/sec is
obstruction.
Most experts are in agreement that somewhere between
20 and 30 cm H2O detrusor pressure associated with a low
flow in a woman is obstruction. We base this on a nomogram
that Asnat Groutz, a brilliant urogynecologist from Israel, and I
devised. It relates pressure and flow, but unlike previous
nomograms, we think it’s very important in women (and in
men) to look at the unintubated flow as well because we think
that the catheter and the act of voiding with a catheter has a
variable effect on flow in these people. In some people, it
doesn’t affect them at all and they void the same with or
without the catheter and then other people have a perfectly
normal flow without a catheter and a very obstructed looking
flow with the catheter.
So we use as our criteria the detrusor pressure at maximum
flow with the urethral catheter in and we compare that to the
best flow with or without a urethral catheter in place. These
two numbers are plotted on the nomogram. But for everyday
diagnosis, it’s still high pressure and low flow and, you can use
some of these cutoffs that we’ve talked about.
Dr. Cameron: Do any of the panel members have any
comments?
Dr. Webster: May I go back to the case itself? The
problem here is we’re looking at things from the wrong
side. We’re cystoscoping going back in and we can’t see
an obstruction and the catheter goes back in and it doesn’t
hit any impediment and yet no urine comes out when
she voids. So either she has profound pelvic floor problems,
which I doubt, or she has a significant structural obstruction.
This is a long-standing problem based on the appearance of
her bladder and the diverticula. What kind of structural
obstructions could we have? We need to look at it from the
other side.
I’ve had two cases that were variations on this theme
where I eventually performed antegrade endoscopy with a
flexible cystoscope. One turned out to be a periurethral
diverticulum in the era before we regularly did MRIs. The
scope went down through the bladder neck into a blind
pocket, and a catheter came up from below through a flap on
the side of it, and her problem was related to this divertic-
ulum.
Now, this is too chronic, I think, for that diagnosis, but what
this experience does tell me is I would do an MRI of the urethra
and I would consider antegrade endoscopy to see just where
the structural obstruction is. It may not help you, but it seems
that stone is still left unturned.
Dr. Blaivas: I think certainly the MRI is a good idea.
When I said we’d do a voiding cystogram it would be just part
of the urodynamics. Cystourethrogram in our experience
discloses most but not all urethral diverticula. Was she to
get worse, we’d have a clearer understanding of where the
obstruction is, and an MRI would be helpful if you think
there’s an extrinsic obstruction, but sometimes we see a
stricture. About half of the people ended up having a
stricture. Whether the stricture was caused by the catheter-
ization in the first place to undo whatever the obstruction was,
I don’t know, but half of my patients do end up with mid
urethral strictures.
Dr. Cameron: She did have an MRI. It showed a bladder
diverticulum, but her urethra looked normal (Fig. 6D).
Dr. Webster: I would say the vast majority of the women
referred to us as urethral strictures turn out to have pelvic
floor dysfunction and behavioral voiding disorders although
this has more the appearance of neurogenic phenomena if
there’s no identifiable structural abnormality.
Dr. Cameron: So, Dr. Blaivas, do you think her voiding
function will ever return to normal?
Dr. Blaivas: If you remove the obstruction, I think there’s a
very good chance it will—almost for sure. Again, the concept
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Fig. 7. Urodynamics tracing of voiding phase. Note detrusor pressure rise to
195 cm of water with a flow of 6 ml/sec at a volume of 362 ml.
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of following her sequentially after treating the obstruction is
very important.
Dr. Cameron: This woman had very large bladder diverti-
cula. Would you try to excise these to improve her bladder
function and emptying?
Dr. Blaivas: Perhaps, but not until you’ve resolved the
other concerns. First and foremost, you must settle the issue
of the urethral obstruction. She’s clearly obstructed, and I
wouldn’t do anything about the diverticulum or even consider
that until such time as I’m confident that I’ve fixed the
obstruction.
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